Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Epand

Showing results (71-80 of 293) with videos related to

Pageof 30
Sort By:
Biochemical and Biophysical Research Communications|August 15, 1994
Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayersR M Epand, R F Epand
Biophysical Journal|December 31, 1997
The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanismsD P Siegel, R M Epand
Biochemistry|August 4, 1981
A calorimetric study of peptide-phospholipid interactions: the glucagon-dimyristoylphosphatidylcholine complexR M Epand, J M Sturtevant
Anti-Cancer Drug Design|July 1, 1991
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cellsR F Epand, R M Epand
Molecular Pharmacology|May 1, 1975
Prostaglandin E1: anomalous effects on glucose production in rat liverG E Wheeler, R M Epand
Biochimica Et Biophysica Acta|December 11, 1999
Diversity of antimicrobial peptides and their mechanisms of actionR M Epand, H J Vogel
Biophysical Journal|May 12, 2009
Studies on the interaction of glucagon with phospholipidsR M Epand, J M Sturtevant
Biochemistry|February 14, 1995
Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical propertiesC D McCallum, R M Epand
Biochemical Society Transactions|January 1, 1977
Lipoprotein complexes between glucagon and dimyristoylglycerophosphocholine (dimyristoyl phosphatidylcholine) [proceedings]A J Jones, R M Epand
Bioscience Reports|March 1, 1987
Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranesJ J Cheetham, R M Epand
Pageof 30

Showing results (71-80 of 293) with videos related to

Sort By:
Pageof 30
Biochemical and Biophysical Research Communications|August 15, 1994
Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayersR M Epand, R F Epand
Biophysical Journal|December 31, 1997
The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanismsD P Siegel, R M Epand
Biochemistry|August 4, 1981
A calorimetric study of peptide-phospholipid interactions: the glucagon-dimyristoylphosphatidylcholine complexR M Epand, J M Sturtevant
Anti-Cancer Drug Design|July 1, 1991
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cellsR F Epand, R M Epand
Molecular Pharmacology|May 1, 1975
Prostaglandin E1: anomalous effects on glucose production in rat liverG E Wheeler, R M Epand
Biochimica Et Biophysica Acta|December 11, 1999
Diversity of antimicrobial peptides and their mechanisms of actionR M Epand, H J Vogel
Biophysical Journal|May 12, 2009
Studies on the interaction of glucagon with phospholipidsR M Epand, J M Sturtevant
Biochemistry|February 14, 1995
Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical propertiesC D McCallum, R M Epand
Biochemical Society Transactions|January 1, 1977
Lipoprotein complexes between glucagon and dimyristoylglycerophosphocholine (dimyristoyl phosphatidylcholine) [proceedings]A J Jones, R M Epand
Bioscience Reports|March 1, 1987
Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranesJ J Cheetham, R M Epand
Pageof 30